Pre-Test Essential and Evolving Strategies for Recognizing and Addressing Agitation Associated with Dementia Due to Alzheimer's Disease: Current and Emerging Therapies for AADAD (Module 3) Pre-Test Which of the following was FDA approved to treat agitation associated with dementia due to AD after demonstrating a statistically significant reduction in the symptoms of agitation over a 12-week treatment period? Aripiprazole Brexpiprazole Olanzapine Risperidone Unsure
